IndraLab

Statements


Ubiquitin affects JOSD2
| 4

sparser
"The covalent complex between Josephin-2 and ubiquitin mimics the covalent thioester intermediate formed during the deubiquitination reaction ( xref )."

sparser
"Additionally, in the covalent complex of JOSD2 and ubiquitin, the ubiquitin molecule is covalently attached to cysteine-24, which moves side chain of this residue away from histine-125 and toward the binding site of the substrate."

sparser
"The crystal asymmetric unit contains a single copy of the ubiquitin-Josephin-2 complex."

sparser
"In order to form a Josephin-2-ubiquitin complex sufficiently stable for crystallization, we covalently linked the enzyme to its substrate using ubiquitin 1–75 -chloroethylamine, an active site-directed ubiquitin analog ( xref )."
TYSND1 affects JOSD2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
TRAPPC2 affects JOSD2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
JOSD2 affects TYSND1
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
JOSD2 affects TRAPPC2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
JOSD2 affects AHCYL2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
JOSD2 affects AHCYL1
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
AHCYL2 affects JOSD2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
AHCYL1 affects JOSD2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
2 |
Valproic acid methylates JOSD2.
1 |
1 |

No evidence text available
Valproic acid increases the amount of JOSD2.
1 |
Valproic acid increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
UBC affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
SPRR3 affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
PITX2 affects JOSD2
2 |
PITX2 decreases the amount of JOSD2. 2 / 2
2 |

No evidence text available

No evidence text available
Niclosamide affects JOSD2
2 |
Niclosamide increases the amount of JOSD2. 2 / 2
2 |

No evidence text available

No evidence text available
MCEMP1 affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
JOSD2 affects runx1
| 2
JOSD2 inhibits runx1.
| 1
JOSD2 inhibits runx1. 1 / 1
| 1

reach
"Finally, JOSD2 decreases AML progression in vivo."
JOSD2 activates runx1.
| 1
JOSD2 activates runx1. 1 / 1
| 1

reach
"Taken together, we propose that JOSD2 blocks PKM2 nuclear localization and reduces AML progression."
| 1 1
| 1

reach
"JOSD2 deficiency displays cytostatic effects and reduces glycolysis in a broad spectrum of tumor cells of distinct origin and its expression correlates with poor prognosis in non small cell lung cancer."
| 1

eidos
"JOSD2 deficiency displays cytostatic effects and reduces glycolysis in a broad spectrum of tumor cells of distinct origin and its expression correlates with poor prognosis in non-small cell lung cancer ."
JOSD2 affects UBC
2 |
2 |

No evidence text available

No evidence text available
JOSD2 affects SPRR3
2 |
2 |

No evidence text available

No evidence text available
JOSD2 affects MCEMP1
2 |
2 |

No evidence text available

No evidence text available

reach
"JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression."

eidos
"JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression ."
JOSD2 affects HBB
2 |
2 |

No evidence text available

No evidence text available
JOSD2 affects DUSP28
2 |
2 |

No evidence text available

No evidence text available
HBB affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
ELK1 affects JOSD2
2 |
ELK1 decreases the amount of JOSD2. 2 / 2
2 |

No evidence text available

No evidence text available
DUSP28 affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
6-propyl-2-thiouracil decreases the amount of JOSD2. 2 / 2
2 |

No evidence text available

No evidence text available
2,3,7,8-tetrachlorodibenzodioxine increases the amount of JOSD2.
1 |
1 |

No evidence text available
2,3,7,8-tetrachlorodibenzodioxine decreases the amount of JOSD2.
1 |
1 |

No evidence text available
17alpha-ethynylestradiol increases the amount of JOSD2.
1 |
17alpha-ethynylestradiol increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
17alpha-ethynylestradiol decreases the amount of JOSD2.
1 |
17alpha-ethynylestradiol decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Zinc atom affects JOSD2
1 |
Zinc atom increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Topotecan affects JOSD2
1 |
Topotecan decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Tetrachloromethane increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
Sodium arsenite increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Oxaliplatin affects JOSD2
1 |
Oxaliplatin decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Nefazodone affects JOSD2
1 |
Nefazodone increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Methyl methanesulfonate increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Glafenine affects JOSD2
1 |
Glafenine increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Flutamide affects JOSD2
1 |
Flutamide increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Decabromodiphenyl ether decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
Cyclosporin A increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Coumarin affects JOSD2
1 |
Coumarin increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
Cobalt dichloride decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Cadmium dichloride increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Atrazine affects JOSD2
1 |
Atrazine increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
Aluminium atom decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
1 |

No evidence text available
Acetamide affects JOSD2
1 |
Acetamide increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
TFAP2C affects JOSD2
1 |
TFAP2C decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
TFAP2A affects JOSD2
1 |
TFAP2A decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
STUB1 affects JOSD2
1 |
1 |

No evidence text available
SP3 affects JOSD2
1 |
SP3 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
SMARCA2 affects JOSD2
1 |
1 |

No evidence text available

No evidence text available
RFX1 affects JOSD2
1 |
RFX1 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
PLA2G2A affects JOSD2
1 |
1 |

No evidence text available
PAX4 affects JOSD2
1 |
PAX4 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
PAX3 affects JOSD2
1 |
PAX3 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
NLRP3 affects JOSD2
| 1
JOSD2 binds NLRP3. 1 / 1
| 1

isi
"This was mediated by enhanced deubiquitination of NLRP3 via binding with deubiquitinases BRCC3 and JOSD2, which are highly expressed in myeloid cells."
NDUFA8 affects JOSD2
1 |
1 |

No evidence text available
MEF2A affects JOSD2
1 |
MEF2A decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
LRTOMT affects JOSD2
1 |
1 |

No evidence text available
K11 affects JOSD2
| 1
| 1

sparser
"The ubiquitin linkage types most readily cleaved by Josephin-2K11, K48, and K63—are all abundant in cells ( xref , xref )."
JOSD2 affects nuclear localization PKM2
| 1
JOSD2 inhibits nuclear localization PKM2. 1 / 1
| 1

eidos
"We then found out that JOSD2 inhibits nuclear localization of PKM2 by reducing its K433 acetylation modification , accompanied by decreased downstream gene expression through non-glycolytic functions ."
| 1
| 1

reach
"Taken together, we propose that JOSD2 blocks PKM2 nuclear localization and reduces AML progression."

reach
"The depletion of JOSD2 promoted YAP/TAZ proteasomal degradation and significantly impeded CCA proliferation in vitro and in vivo ."
JOSD2 affects cell death
| 1
| 1

reach
"Furthermore, in contrast to the control siRNA treated cells, siRNA depletion of JOSD2 caused selective cell death in high-PHGDH-expressing cells, but not in low expressing cell lines."
JOSD2 affects YAP1
| 1
JOSD2 inhibits YAP1. 1 / 1
| 1

reach
"The depletion of JOSD2 promoted YAP/TAZ proteasomal degradation and significantly impeded CCA proliferation in vitro and in vivo ."
JOSD2 affects YAP TAZ proteasomal
| 1
JOSD2 activates YAP TAZ proteasomal. 1 / 1
| 1

eidos
"The depletion of JOSD2 promoted YAP / TAZ proteasomal degradation and significantly impeded CCA proliferation in vitro and in vivo ."
JOSD2 affects Wnt pathway transduction
| 1
JOSD2 inhibits Wnt pathway transduction. 1 / 1
| 1

eidos
"Importantly , a mechanistic study revealed that JOSD2 binds to and decreases the ubiquitination level of catenin beta 1 ( CTNNB1 ) , a key component of Wnt signaling , thereby augmenting Wnt pathway transduction ."
JOSD2 affects TAFAZZIN
| 1
| 1

reach
"The depletion of JOSD2 promoted YAP/TAZ proteasomal degradation and significantly impeded CCA proliferation in vitro and in vivo ."
JOSD2 affects STUB1
1 |
1 |

No evidence text available
JOSD2 affects SMARCA2
1 |
1 |

No evidence text available
JOSD2 affects PLA2G2A
1 |
1 |

No evidence text available
JOSD2 affects PKM2 nuclear localization
| 1
JOSD2 inhibits PKM2 nuclear localization. 1 / 1
| 1

eidos
"Taken together , we propose that JOSD2 blocks PKM2 nuclear localization and reduces AML progression ."
JOSD2 affects PKM
| 1
JOSD2 inhibits PKM. 1 / 1
| 1

reach
"Taken together, we propose that JOSD2 blocks PKM2 nuclear localization and reduces AML progression."
JOSD2 affects NLRP3
| 1
JOSD2 binds NLRP3. 1 / 1
| 1

isi
"This was mediated by enhanced deubiquitination of NLRP3 via binding with deubiquitinases BRCC3 and JOSD2, which are highly expressed in myeloid cells."
JOSD2 affects NDUFA8
1 |
1 |

No evidence text available
JOSD2 affects LRTOMT
1 |
1 |

No evidence text available
JOSD2 affects K11
| 1
| 1

sparser
"The ubiquitin linkage types most readily cleaved by Josephin-2K11, K48, and K63—are all abundant in cells ( xref , xref )."
JOSD2 affects FBN2
| 1
JOSD2 activates FBN2. 1 / 1
| 1

reach
"The depletion of JOSD2 promoted YAP/TAZ proteasomal degradation and significantly impeded CCA proliferation in vitro and in vivo ."
JOSD2 affects FAM126A
| 1
JOSD2 activates FAM126A. 1 / 1
| 1

reach
"Furthermore, a series of rescue experiments confirmed the significance of CTNNB1 in the modulation of HCC progression by JOSD2."

reach
"Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression."
| 1

reach
"Reconstitute of JOSD2 in AML cells significantly inhibit cell viability and induce cell apoptosis."

reach
"Deubiquitinating enzyme JOSD2 promotes hepatocellular carcinoma progression through interacting with and inhibiting CTNNB1 degradation."
JOSD2 affects CTNNB1
| 1
JOSD2 activates CTNNB1. 1 / 1
| 1

reach
"Deubiquitinating enzyme JOSD2 promotes hepatocellular carcinoma progression through interacting with and inhibiting CTNNB1 degradation."
JOSD2 affects COMMD3
1 |
1 |

No evidence text available
JOSD2 affects BRCC3
| 1
BRCC3 binds JOSD2. 1 / 1
| 1

isi
"This was mediated by enhanced deubiquitination of NLRP3 via binding with deubiquitinases BRCC3 and JOSD2, which are highly expressed in myeloid cells."
ICG 001 affects JOSD2
1 |
ICG 001 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
GCM1 affects JOSD2
1 |
GCM1 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
GATA1 affects JOSD2
1 |
GATA1 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
COMMD3 affects JOSD2
1 |
1 |

No evidence text available
1 |
C646 compound decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
BRCC3 affects JOSD2
| 1
BRCC3 binds JOSD2. 1 / 1
| 1

isi
"This was mediated by enhanced deubiquitination of NLRP3 via binding with deubiquitinases BRCC3 and JOSD2, which are highly expressed in myeloid cells."
AR affects JOSD2
1 |
AR decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
(+)-JQ1 compound decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |

No evidence text available